12
May
A number of dess, differing in design and composition, are currently available for clinical use and are summarised in figure 1. Licensed from abbott laboratories (which sells under the xience.
The stent is usually placed within the peripheral or coronary artery by an interventional cardiologist.
Promus drug eluting stent. The carrier releases the drug in a gradual and controlled fashion (elution), allowing local diffusion into the vascular tissue, thus preventing excessive cell growth (neointimal. 2 xience™ stent allows interventional cardiologists (ics) to achieve the positive outcomes they want for their patients. The secondary endpoint was stent thrombosis (st) at 1 year.
Platinum chromium coronary stent system. This prevents fibrosis that, together with clots, could otherwise block the stented artery, a process called restenosis. The polymer coatings on des elute antiproliferative drugs to inhibit intimal proliferation and.
The promus elite stent system builds on the proven performance of the promus permanent polymer des family and the platinum chromium (ptcr) platform with a new enhanced delivery system for outstanding deliverability and acute performance. ≥ 2.50 mm to ≤ 4.25 mm in diameter compared to the xience cocr ees. Acute coronary syndrome (acs) was.
A number of dess, differing in design and composition, are currently available for clinical use and are summarised in figure 1. Boston scientific ($bsx) back story: The coating comprises two layers.
Elliptical ratio, 1.02±0.01 to 1.04±0.01 vs. Whatever the design, repot maintained vessel circularity compared to fkb: Evaluate the safety and effectiveness of the promus ptcr ees stent system1 for the treatment of patients with up to 2 de novo lesions ≤ 24 mm in length;
The stent component of the promus element plus stent system (referred to as the promus element stent) is a ptcr element stent with a drug/polymer coating. Licensed from abbott laboratories (which sells under the xience. 1 coronary stents have substantially evolved since their first use in the 1980s due to continuous work to refine their design, structure and materials.
Section 6.11 magnetic resonance imaging (mri) safety information The primary endpoint was the composite of major adverse cardiac and cerebral events (macce) defined as cardiac death, myocardial infarction (mi), target lesion revascularization (tlr), and stroke assessed after 1 year. Proximal elliptical ratio, side branch obstruction (sbo), stent overstretch and strut malapposition were quantified on 2d and 3d oct.
Synergy bioabsorbable polymer coronary stent system; The promus premier stent system features the only customized stent architecture of its kind providing strength without compromising flexibility. Stent length (mm) delivery system length (cm) us fda indicated use.
Below is an excerpt of section 6.11 from the directions for use detailing the safety of performing mri following the placement of a promus premier stent. In 2 belgian centers, 3 german centers and 1 new zealand center a total of 70 patients will be recruited. Pathophysiology of late stent thrombosis after des implantation.
The stent is usually placed within the peripheral or coronary artery by an interventional cardiologist. Taxus express² coronary stent system; Food and drug administration (fda) approval, the promus stent is expected to become available in the united states in 2008.
Results were compared to fkb with promus premier.